Today: 20 May 2026
Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies
13 November 2025
2 mins read

Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Live price snapshot
Aviva (LSE: AV.) traded at 664.60p at 09:53 GMT, down 28.00p (-4.04%) versus Wednesday’s close. Intraday, the stock has moved between 656.08p and 675.99p; its 52‑week range stands at 451.90p–698.40p. Figures are delayed and time‑stamped.

What’s moving the shares
The drop follows Aviva’s third‑quarter trading update and “In Focus” presentation, which raised medium‑term ambitions and nearly doubled expected cost savings from the Direct Line acquisition. Management now targets operating EPS growth of 11% (2025–2028 CAGR), IFRS ROE above 20% by 2028, and >£7bn cash remittances over 2026–2028. Cost synergies from Direct Line are lifted to £225m (run‑rate in 2028), with >£0.5bn of capital synergies expected by end‑2026 (subject to approvals). Aviva also guided to ~£2.2bn group operating profit for 2025, including ~£0.15bn from Direct Line. Shares fell despite the upgrade, after a strong year‑to‑date rally that set a high bar for today’s news. Reuters+3Aviva+3Aviva+3

Key numbers from today’s update (13 Nov)

  • New Group targets: 11% operating EPS CAGR (2025–2028); >20% IFRS ROE by 2028; >£7bn cash remittances (2026–2028).
  • Direct Line synergies:£225m cost savings (run‑rate in 2028), plus >£0.5bn capital synergies by end‑2026; ~£350m total costs to achieve.
  • 2025 profit guide:~£2.2bn operating profit, including ~£0.15bn from Direct Line.
  • Q3 trading highlights: General‑insurance premiums +12% to £10.0bn (9M); wealth net inflows £8.3bn with assets of £224bn; Solvency II shareholder coverage 177% (end‑Oct).
  • Capital returns: Aviva signalled a restart of regular share buybacks with FY2025 results next March, alongside its dividend policy.

Why the market reaction looks muted despite stronger guidance
After rallying roughly 48% year‑to‑date into this morning, Aviva needed a genuinely surprising step‑up to extend gains; early trading suggests investors are banking profits and digesting execution risks and cost‑to‑achieve (~£350m) on the Direct Line integration. The company’s stronger targets and faster synergy timetable are clear positives, but today’s move hints that a portion was already priced in.

What to watch next

  • Integration milestones: Aviva expects about £40m of synergy savings to be in place by year‑end 2025, with the full £225m cost benefit by 2028; capital synergies >£0.5bn depend on regulatory approvals expected around end‑2026. Execution against these markers is the near‑term yardstick.
  • Capital returns timing: Management plans to reintroduce buybacks alongside FY2025 results in March 2026—a potential catalyst if markets remain favourable.
  • Diary date: FY2025 results are scheduled for 5 March 2026 (provisional).

Aviva share price: today’s quick facts (as of mid‑morning, London time)

  • Price: 664.60p; Change: −4.04% vs. prior close.
  • Day range: 656.08p–675.99p; 52‑week range: 451.90p–698.40p.
  • Context: Stock down on the day after guidance upgrades and synergy uplift tied to the Direct Line deal; management also signalled the return of larger buybacks next year.

All market prices are delayed/timed as cited above and can change during the session. This article is for information only and not investment advice.

Stock Market Today

  • Australian Shares Fall Below 8,500 Support Amid Inflation Worries
    May 20, 2026, 5:45 AM EDT. Australian shares closed below the key 8,500 support level for the first time since late March. Persistent inflation concerns linked to the Iran war weighed on investor sentiment. The benchmark S&P/ASX 200 index fell amid price pressures, reflecting broader caution in the market. Rising inflation tends to erode purchasing power and corporate profits, prompting investors to reassess valuations. The fall highlights sustained uncertainties in global markets impacting Australia's equity performance.

Latest articles

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?
Previous Story

Rolls‑Royce Share Price Today (13 Nov 2025): RR.L edges lower after in‑line trading update as guidance held and flying hours rise

NICE Ltd. (NICE) Stock Pops as Q3 2025 Earnings Showcase AI‑Driven Cloud Growth and Raised Revenue Guidance
Next Story

NICE Ltd. (NICE) Stock Pops as Q3 2025 Earnings Showcase AI‑Driven Cloud Growth and Raised Revenue Guidance

Go toTop